D.A. Davidson & Co’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $508K | Buy |
54,120
+28,100
| +108% | +$264K | ﹤0.01% | 1051 |
|
2025
Q1 | $185K | Buy |
26,020
+11,250
| +76% | +$80K | ﹤0.01% | 1332 |
|
2024
Q4 | $172K | Sell |
14,770
-1,480
| -9% | -$17.3K | ﹤0.01% | 1353 |
|
2024
Q3 | $334K | Buy |
16,250
+4,150
| +34% | +$85.3K | ﹤0.01% | 1151 |
|
2024
Q2 | $271K | Buy |
+12,100
| New | +$271K | ﹤0.01% | 1202 |
|
2018
Q4 | – | Sell |
-10,166
| Closed | -$291K | – | 1146 |
|
2018
Q3 | $291K | Sell |
10,166
-8,729
| -46% | -$250K | 0.01% | 924 |
|
2018
Q2 | $517K | Sell |
18,895
-324
| -2% | -$8.87K | 0.01% | 692 |
|
2018
Q1 | $405K | Buy |
19,219
+2,395
| +14% | +$50.5K | 0.01% | 761 |
|
2017
Q4 | $323K | Buy |
+16,824
| New | +$323K | 0.01% | 812 |
|